182 related articles for article (PubMed ID: 34742871)
1. CYLD destabilizes NoxO1 protein by promoting ubiquitination and regulates prostate cancer progression.
Haq S; Sarodaya N; Karapurkar JK; Suresh B; Jo JK; Singh V; Bae YS; Kim KS; Ramakrishna S
Cancer Lett; 2022 Jan; 525():146-157. PubMed ID: 34742871
[TBL] [Abstract][Full Text] [Related]
2. NADPH Oxidase 1 Activity and ROS Generation Are Regulated by Grb2/Cbl-Mediated Proteasomal Degradation of NoxO1 in Colon Cancer Cells.
Joo JH; Oh H; Kim M; An EJ; Kim RK; Lee SY; Kang DH; Kang SW; Keun Park C; Kim H; Lee SJ; Lee D; Seol JH; Bae YS
Cancer Res; 2016 Feb; 76(4):855-65. PubMed ID: 26781991
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of miR‑181b inhibits human colon cancer cell proliferation by targeting CYLD and inhibiting the NF‑κB signaling pathway.
Yang X; Sun Y; Zhang Y; Han S
Int J Mol Med; 2020 Nov; 46(5):1755-1764. PubMed ID: 32901872
[TBL] [Abstract][Full Text] [Related]
4. IκB kinase promotes Nrf2 ubiquitination and degradation by phosphorylating cylindromatosis, aggravating oxidative stress injury in obesity-related nephropathy.
Chen YY; Hong H; Lei YT; Zou J; Yang YY; He LY
Mol Med; 2021 Oct; 27(1):137. PubMed ID: 34711178
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of deubiquitinase CYLD enhances therapeutic antibody production in Chinese hamster ovary cells.
Lu Y; Zhou Q; Han Q; Wu P; Zhang L; Zhu L; Weaver DT; Xu C; Zhang B
Appl Microbiol Biotechnol; 2018 Jul; 102(14):6081-6093. PubMed ID: 29766242
[TBL] [Abstract][Full Text] [Related]
6. CYLD regulates cell ferroptosis through Hippo/YAP signaling in prostate cancer progression.
Gu Y; Wu S; Fan J; Meng Z; Gao G; Liu T; Wang Q; Xia H; Wang X; Wu K
Cell Death Dis; 2024 Jan; 15(1):79. PubMed ID: 38246916
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-301b promotes cell proliferation and apoptosis resistance in triple-negative breast cancer by targeting CYLD.
Song H; Li D; Wu T; Xie D; Hua K; Hu J; Deng X; Ji C; Deng Y; Fang L
BMB Rep; 2018 Nov; 51(11):602-607. PubMed ID: 30269739
[TBL] [Abstract][Full Text] [Related]
8. CYLD Deubiquitinates Nicotinamide Adenine Dinucleotide Phosphate Oxidase 4 Contributing to Adventitial Remodeling.
Yu B; Liu Z; Fu Y; Wang Y; Zhang L; Cai Z; Yu F; Wang X; Zhou J; Kong W
Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1698-1709. PubMed ID: 28751569
[TBL] [Abstract][Full Text] [Related]
9. The E3 ubiquitin ligase MIB2 enhances inflammation by degrading the deubiquitinating enzyme CYLD.
Uematsu A; Kido K; Takahashi H; Takahashi C; Yanagihara Y; Saeki N; Yoshida S; Maekawa M; Honda M; Kai T; Shimizu K; Higashiyama S; Imai Y; Tokunaga F; Sawasaki T
J Biol Chem; 2019 Sep; 294(38):14135-14148. PubMed ID: 31366726
[TBL] [Abstract][Full Text] [Related]
10. Subquinocin, a small molecule inhibitor of CYLD and USP-family deubiquitinating enzymes, promotes NF-κB signaling.
Yamanaka S; Sato Y; Oikawa D; Goto E; Fukai S; Tokunaga F; Takahashi H; Sawasaki T
Biochem Biophys Res Commun; 2020 Mar; 524(1):1-7. PubMed ID: 31898971
[TBL] [Abstract][Full Text] [Related]
11. The Potential of Cylindromatosis (CYLD) as a Therapeutic Target in Oxidative Stress-Associated Pathologies: A Comprehensive Evaluation.
Huang Z; Tan Y
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176077
[TBL] [Abstract][Full Text] [Related]
12. Dishevelled proteins and CYLD reciprocally regulate each other in CML cell lines.
Çalışkan C; Pehlivan M; Yüce Z; Sercan O
Mol Biol Rep; 2017 Oct; 44(5):391-397. PubMed ID: 28840581
[TBL] [Abstract][Full Text] [Related]
13. Cylindromatosis Tumor Suppressor Protein (CYLD) Deubiquitinase is Necessary for Proper Ubiquitination and Degradation of the Epidermal Growth Factor Receptor.
Sanchez-Quiles V; Akimov V; Osinalde N; Francavilla C; Puglia M; Barrio-Hernandez I; Kratchmarova I; Olsen JV; Blagoev B
Mol Cell Proteomics; 2017 Aug; 16(8):1433-1446. PubMed ID: 28572092
[TBL] [Abstract][Full Text] [Related]
14. miR-130b regulates B cell proliferation via CYLD-mediated NF-κB signaling.
Wu M; Zhao J; Wu W; Hao C; Yang Y; Zhang J
Exp Cell Res; 2024 Jan; 434(1):113870. PubMed ID: 38049082
[TBL] [Abstract][Full Text] [Related]
15. LncRNA GMDS-AS1 inhibits lung adenocarcinoma development by regulating miR-96-5p/CYLD signaling.
Zhao M; Xin XF; Zhang JY; Dai W; Lv TF; Song Y
Cancer Med; 2020 Feb; 9(3):1196-1208. PubMed ID: 31860169
[TBL] [Abstract][Full Text] [Related]
16. miR-501 is upregulated in cervical cancer and promotes cell proliferation, migration and invasion by targeting CYLD.
Sanches JGP; Xu Y; Yabasin IB; Li M; Lu Y; Xiu X; Wang L; Mao L; Shen J; Wang B; Hou L; Ju J; Zhao J; Song B
Chem Biol Interact; 2018 Apr; 285():85-95. PubMed ID: 29477382
[TBL] [Abstract][Full Text] [Related]
17. miR-182 controls cell growth in gastrointestinal stromal tumors by negatively regulating CYLD expression.
Ling T; Yu F; Cao H
Oncol Rep; 2018 Dec; 40(6):3705-3713. PubMed ID: 30542706
[TBL] [Abstract][Full Text] [Related]
18. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.
Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X
Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938
[No Abstract] [Full Text] [Related]
19. Cycles of ubiquitination and deubiquitination critically regulate growth factor-mediated activation of Akt signaling.
Yang WL; Jin G; Li CF; Jeong YS; Moten A; Xu D; Feng Z; Chen W; Cai Z; Darnay B; Gu W; Lin HK
Sci Signal; 2013 Jan; 6(257):ra3. PubMed ID: 23300340
[TBL] [Abstract][Full Text] [Related]
20. Reciprocal activation between STAT3 and miR-181b regulates the proliferation of esophageal cancer stem-like cells via the CYLD pathway.
Xu DD; Zhou PJ; Wang Y; Zhang L; Fu WY; Ruan BB; Xu HP; Hu CZ; Tian L; Qin JH; Wang S; Wang X; Li YC; Liu QY; Ren Z; Zhang R; Wang YF
Mol Cancer; 2016 May; 15(1):40. PubMed ID: 27189061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
